Europe
Loading...
| Exchange | Trading Currency | Ticker | Listing Date | SEDOL | Net Asset Value (NAV) | Shares Outstanding | Net Assets |
|---|---|---|---|---|---|---|---|
Stand aktuell Monatsende & Viertelende (31 Dec 2025) | ETF | Index | Differenz |
|---|---|---|---|
| 1 Jahr | 18.86% | 19.35% | -0.49% |
| 3 Jahre | -3.04% | -2.53% | -0.51% |
| Seit Gründung | -14.25% | -13.83% | -0.42% |
| Net Assets (%) | Ticker | Name | Country | SEDOL | Market Price | Shares Held | Market Value |
|---|---|---|---|---|---|---|---|
| Sektor | Weight (%) | |
|---|---|---|
| Health Care | 100.0 |
| Land | Weight (%) | |
|---|---|---|
| United States | 82.9 | |
| Netherlands | 4.8 | |
| Germany | 3.5 | |
| Switzerland | 3.3 | |
| Britain | 2.1 | |
| Singapore | 1.8 | |
| China | 1.6 |
| Branche | Weight (%) | |
|---|---|---|
| Pharmaceuticals, Biotechnology & Life Sciences | 91.3 | |
| Health Care Equipment & Services | 8.7 |
| Eigenkapitalrendite | -19.60% | |
| Gewichtete durchschnittliche Marktkapitalisierung | 49,806 M | |
| 2025 | 2026 | |
| Kurs-Gewinn-Verhältnis | -21.32 | -31.58 |
| Kurs-Buchwert | 5.57 | 6.99 |
| Type of Loan Security | USD Cash | Sovereign Debt |
|---|---|---|
| U.S. Equity and Corporate Securities (including ADRs) | 102% | 105% |
| U.S. Treasury Securities | 105% | 105% |
| U.S. Treasury and Agency Securities | 102% | 105% |
Der Global X Genomics & Biotechnology UCITS ETF (GNOM LN) soll in Unternehmen investieren, die möglicherweise von weiteren Fortschritten der Genomwissenschaft profitieren können, einschließlich Unternehmen, die an der Genbearbeitung, Genomsequenzierung, Genmedizin/-therapie, Computergenomik und Biotechnologie beteiligt sind.
| Börse | Handelswährung | Ticker | Auflegungsdatum | SEDOL | Net Asset Value (NAV) | Anteile in Umlauf | Nettovermögen der Anteilsklasse |
|---|---|---|---|---|---|---|---|
| London Stock Exchange | USD | GNOM LN | 04 Nov 2021 | BP49D86 | $8.54 (4.15%) | 2,420,000 | $20,655,980.80 |
| London Stock Exchange | GBP | GNOG LN | 04 Nov 2021 | BP49D97 | -- | -- | -- |
| Borsa Italiana | EUR | GNOM IM | 18 Nov 2021 | BP49DD1 | -- | -- | -- |
| Deutsche Börse Xetra | EUR | GN0M GY | 11 Nov 2021 | BP49DB9 | -- | -- | -- |
| SIX Swiss Exchange | CHF | GNOM SW | 06 Dec 2021 | BP49DC0 | -- | -- | -- |
| Nettovermögen (%) | Ticker | Name | Land | SEDOL | Marktpreis ($) | Anteile gehalten | Marktwert ($) |
|---|---|---|---|---|---|---|---|
| 6.37 | ARWR | ARROWHEAD PHARMACEUTICALS IN | US | BYQBFJ8 | 70.81 | 18,575 | 1,315,295.75 |
| 5.62 | GH | GUARDANT HEALTH INC | US | BFXC911 | 112.33 | 10,329 | 1,160,256.57 |
| 5.59 | ILMN | ILLUMINA INC | US | 2613990 | 147.11 | 7,854 | 1,155,401.94 |
| 5.22 | MRNA | MODERNA INC | US | BGSXTS3 | 35.66 | 30,228 | 1,077,930.48 |
| 5.04 | PRAX | PRAXIS PRECISION MEDICINES I | US | BQ721R4 | 272.90 | 3,815 | 1,041,113.50 |
| 4.66 | NTRA | NATERA INC | US | BYQRG48 | 248.74 | 3,872 | 963,121.28 |
| 4.20 | BMRN | BIOMARIN PHARMACEUTICAL INC | US | 2437071 | 60.07 | 14,436 | 867,170.52 |
| 4.07 | VRTX | VERTEX PHARMACEUTICALS INC | US | 2931034 | 468.38 | 1,794 | 840,273.72 |
| 3.82 | TECH | BIO-TECHNE CORP | US | BSHZ3Q0 | 65.28 | 12,073 | 788,125.44 |
| 3.76 | RNA | AVIDITY BIOSCIENCES INC | US | BMWHPY1 | 72.25 | 10,750 | 776,687.50 |
